Advertisement
Case Report|Articles in Press, 100491

Capillary leak syndrome with pulmonary edema preceded by organizing pneumonia caused by combination therapy with nivolumab and ipilimumab: A Case Report

  • Hiroaki Tachi
    Correspondence
    Corresponding author: Hiroaki Tachi, Department of Respiratory Medicine, Hitachi General Hospital, Hitachi, Ltd, 2-1-1, Jonan, Hitachi City, Ibaraki, Japan, Tel.: +81-294-23-1111, Fax: +81-294-23-8767,
    Affiliations
    Department of Respiratory Medicine, Hitachi General Hospital, Hitachi, Ltd, 2-1-1, Jonan, Hitachi City, Ibaraki, Japan
    Search for articles by this author
Open AccessPublished:February 24, 2023DOI:https://doi.org/10.1016/j.jtocrr.2023.100491
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Treatment with drugs can cause lung disorders. Immune checkpoint inhibitors are often associated with organizing pneumonia. Capillary leak syndrome is a clinical form of drug-induced lung injury, a rare condition characterized by hemoconcentration, hypoalbuminemia, and hypovolemic shock. There have been no reports of multiple lung injury with immune checkpoint inhibitors, and although capillary leak syndrome alone has been reported in the past, there have been no reports of pulmonary edema as a complication. We report a 68-year-old woman who died of respiratory and circulatory failure due to pulmonary edema caused by capillary leak syndrome, preceded by organizing pneumonia induced by combination therapy with nivolumab and ipilimumab for postoperative recurrence of lung adenocarcinoma. Residual inflammation and immune abnormalities from prior immune-related pulmonary adverse events may have increased pulmonary capillary permeability, leading to marked pulmonary edema.

      Keywords